January 26, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
NovoPen Echo now available in US
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Novo Nordisk’s NovoPen Echo is now available in the United States, according to a press release.
The NovoPen Echo is said to be the first and only diabetes pen device in the US with half-unit dosing and a memory function that has the capability to record dosages and time passed since the last injection, according to the press release.
NovoPen Echo will be available to patients who use insulin aspart (NovoLog) PenFill cartridges.
According to the press release, the device’s half-unit dosing versatility will give patients accurate adjustments. Customizable, decorative skins will also be available for the devices’ pediatric users. The product has already been launched in Europe, Canada, and Israel.